|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Casey SC, Li Y, Fan AC and Felsher DW:
Oncogene withdrawal engages the immune system to induce sustained
cancer regression. J Immunother Cancer. 2:242014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kenny PA, Lee GY and Bissell MJ: Targeting
the tumor microenvironment. Front Biosci. 12:3468–3474. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu Y and Cao X: The origin and function
of tumor-associated macrophages. Cell Mol Immunol. 12:1–4. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ostuni R, Kratochvill F, Murray PJ and
Natoli G: Macrophages and cancer: From mechanisms to therapeutic
implications. Trends Immunol. 36:229–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ruffell B, Au A, Rugo HS, Esserman LJ,
Hwang ES and Coussens LM: Leukocyte composition of human breast
cancer. Proc Natl Acad Sci USA. 109:2796–2801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kerkar SP and Restifo NP: Cellular
constituents of immune escape within the tumor microenvironment.
Cancer Res. 72:3125–3130. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lopes RL, Borges TJ, Zanin RF and Bonorino
C: IL-10 is required for polarization of macrophages to M2-like
phenotype by mycobacterial DnaK (heat shock protein 70). Cytokine.
85:123–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ribatti D: Mast cells and macrophages
exert beneficial and detrimental effects on tumor progression and
angiogenesis. Immunol Lett. 152:83–88. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pal R, Chakraborty B, Nath A, Singh LM,
Ali M, Rahman DS, Ghosh SK, Basu A, Bhattacharya S, Baral R, et al:
Noble metal nanoparticle-induced oxidative stress modulates tumor
associated macrophages (TAMs) from an M2 to M1 phenotype: An in
vitro approach. Int Immunopharmacol. 38:332–341. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mantovani A and Sica A: Macrophages,
innate immunity and cancer: Balance, tolerance, and diversity. Curr
Opin Immunol. 22:231–237. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reinartz S, Schumann T, Finkernagel F,
Wortmann A, Jansen JM, Meissner W, Krause M, Schwörer AM, Wagner U,
Müller-Brüsselbach S, et al: Mixed-polarization phenotype of
ascites-associated macrophages in human ovarian carcinoma:
Correlation of CD163 expression, cytokine levels and early relapse.
Int J Cancer. 134:32–42. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baroni S, Romero-Cordoba S, Plantamura I,
Dugo M, D'Ippolito E, Cataldo A, Cosentino G, Angeloni V, Rossini
A, Daidone MG, et al: Exosome-mediated delivery of miR-9 induces
cancer-associated fibroblast-like properties in human breast
fibroblasts. Cell Death Dis. 7:e23122016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo Z, Wang Q, Lau WB, Lau B, Xu L, Zhao
L, Yang H, Feng M, Xuan Y, Yang Y, et al: Tumor microenvironment:
The culprit for ovarian cancer metastasis? Cancer Lett.
377:174–182. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saleem SN and Abdel-Mageed AB:
Tumor-derived exosomes in oncogenic reprogramming and cancer
progression. Cell Mol Life Sci. 72:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nawaz M, Fatima F, Nazarenko I, Ekström K,
Murtaza I, Anees M, Sultan A, Neder L, Camussi G, Valadi H, et al:
Extracellular vesicles in ovarian cancer: Applications to tumor
biology, immunotherapy and biomarker discovery. Expert Rev
Proteomics. 13:395–409. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Krtolica A and Ludlow JW: Hypoxia arrests
ovarian carcinoma cell cycle progression, but invasion is
unaffected. Cancer Res. 56:1168–1173. 1996.PubMed/NCBI
|
|
19
|
Krishnamachary B, Berg-Dixon S, Kelly B,
Agani F, Feldser D, Ferreira G, Iyer N, LaRusch J, Pak B, Taghavi
P, et al: Regulation of colon carcinoma cell invasion by
hypoxia-inducible factor 1. Cancer Res. 63:1138–1143.
2003.PubMed/NCBI
|
|
20
|
Yoon SO, Shin S and Mercurio AM: Hypoxia
stimulates carcinoma invasion by stabilizing microtubules and
promoting the Rab11 trafficking of the alpha6beta4 integrin. Cancer
Res. 65:2761–2769. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
King HW, Michael MZ and Gleadle JM:
Hypoxic enhancement of exosome release by breast cancer cells. BMC
Cancer. 12:4212012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berchem G, Noman MZ, Bosseler M, Paggetti
J, Baconnais S, Le Cam E, Nanbakhsh A, Moussay E, Mami-Chouaib F,
Janji B, et al: Hypoxic tumor-derived microvesicles negatively
regulate NK cell function by a mechanism involving TGF-β and miR23a
transfer. OncoImmunology. 5:e10629682015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li L, Li C, Wang S, Wang Z, Jiang J, Wang
W, Li X, Chen J, Liu K, Li C, et al: Exosomes derived from hypoxic
oral squamous cell carcinoma cells deliver miR-21 to normoxic cells
to elicit a prometastatic phenotype. Cancer Res. 76:1770–1780.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ying X, Wu Q, Wu X, Zhu Q and Wang X,
Jiang L, Chen X and Wang X: Epithelial ovarian cancer-secreted
exosomal miR-222-3p induces polarization of tumor-associated
macrophages. Oncotarget. 7:43076–43087. 2016.PubMed/NCBI
|
|
25
|
Montecalvo A, Larregina AT, Shufesky WJ,
Stolz DB, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G,
Wang Z, et al: Mechanism of transfer of functional microRNAs
between mouse dendritic cells via exosomes. Blood. 119:756–766.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang HW, Liu GH, Liu YQ, Zhao HC, Yang Z,
Zhao CL, Zhang XF and Ye H: Over-expression of microRNA-940
promotes cell proliferation by targeting GSK3β and sFRP1 in human
pancreatic carcinoma. Biomed Pharmacother. 83:593–601. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X, Kwong A, Sihoe A and Chu KM: Plasma
miR-940 may serve as a novel biomarker for gastric cancer. Tumour
Biol. 37:3589–3597. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su S, Liu Q, Chen J, Chen J, Chen F, He C,
Huang D, Wu W, Lin L, Huang W, et al: A positive feedback loop
between mesenchymal-like cancer cells and macrophages is essential
to breast cancer metastasis. Cancer Cell. 25:605–620. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Desir S, Dickson EL, Vogel RI, Thayanithy
V, Wong P, Teoh D, Geller MA, Steer CJ, Subramanian S and Lou E:
Tunneling nanotube formation is stimulated by hypoxia in ovarian
cancer cells. Oncotarget. 7:43150–43161. 2016.PubMed/NCBI
|
|
30
|
Leblond MM, Gérault AN, Corroyer-Dulmont
A, MacKenzie ET, Petit E, Bernaudin M and Valable S: Hypoxia
induces macrophage polarization and re-education toward an M2
phenotype in U87 and U251 glioblastoma models. OncoImmunology.
5:e10564422015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang J, Cao J, Ma S, Dong R, Meng W, Ying
M, Weng Q, Chen Z, Ma J, Fang Q, et al: Tumor hypoxia enhances
non-small cell lung cancer metastasis by selectively promoting
macrophage M2 polarization through the activation of ERK signaling.
Oncotarget. 5:9664–9677. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Saini U, Naidu S, ElNaggar AC, Bid HK,
Wallbillich JJ, Bixel K, Bolyard C, Suarez AA, Kaur B, Kuppusamy P,
et al: Elevated STAT3 expression in ovarian cancer ascites promotes
invasion and metastasis: A potential therapeutic target. Oncogene.
36:168–181. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu Y, Deng W, McGinley EC and DJ II
Klinke: Melanoma exosomes deliver a complex biological payload that
upregulates PTPN11 to suppress T lymphocyte function. Pigment Cell
Melanoma Res. 30:203–218. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu L, Zhang X, Zhang B, Shi H, Yuan X, Sun
Y, Pan Z, Qian H and Xu W: Exosomes derived from gastric cancer
cells activate NF-κB pathway in macrophages to promote cancer
progression. Tumour Biol. 37:12169–12180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Beatson R, Tajadura-Ortega V, Achkova D,
Picco G, Tsourouktsoglou TD, Klausing S, Hillier M, Maher J, Noll
T, Crocker PR, et al: The mucin MUC1 modulates the tumor
immunological microenvironment throughengagement of the lectin
Siglec-9. Nat Immunol. 17:1273–1281. 2016. View Article : Google Scholar : PubMed/NCBI
|
